Related Experiment Video
Updated: Dec 23, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway
Fengxia Yan1,2, Rifang Liao1,3, Marta Silva1
1Faculty of Health Sciences, University of Macau, Macau, China.
Abstract:
Uveal melanoma (UM) is a highly invasive intraocular malignancy with high mortality. Presently, there is no FDA-approved standard for the treatment of metastatic UM. Pristimerin is a natural quinine methide triterpenoid compound with anti-angiogenic, anti-cancer and anti-inflammatory activities. However, Pristimerin potential cytotoxic effect on UM was poorly investigated. In the present study, we found the migration and invasion of UM-1 cells were inhibited by Pristimerin which also caused a rapid increase of ROS, decreased mitochondrial membrane potential, induced the accumulation of cells in G0/G1 phase, ending with apoptotic cell death. Pristimerin inhibited Akt and FoxO3a phosphorylation and induced nuclear accumulation of FoxO3a in UM-1 cells, increased the expression of pro-apoptotic proteins Bim、p27Kip1 , cleaved caspase-3, PARP and Bax, and decreased the expression of Cyclin D1 and Bcl-2. LY294002 or Akt-siRNA inhibited the PI3K/Akt/FoxO3a pathway and promoted the Pristimerin-induced apoptosis, while Pristimerin effects were partially abolished in FoxO3a knockdown UM-1 cell cultures. Taken together, present results showed that Pristimerin induced apoptotic cell death through inhibition of PI3K/Akt/FoxO3a pathway in UM-1 cells. These findings indicate that Pristimerin may be considered as a potential chemotherapeutic agent for patients with UM.
Insights
Pristimerin, a natural compound, effectively inhibits uveal melanoma (UM) cell migration and invasion. It induces apoptotic cell death by targeting the PI3K/Akt/FoxO3a pathway, suggesting its potential as a UM chemotherapeutic agent.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Uveal melanoma (UM) is an aggressive eye cancer with limited treatment options for metastatic disease.
- Pristimerin, a triterpenoid compound, exhibits anti-cancer properties but its effect on UM is largely unexplored.
- There is a critical need for novel therapeutic strategies against metastatic UM.
Purpose of the Study:
- To investigate the cytotoxic effects of Pristimerin on uveal melanoma cells.
- To elucidate the underlying molecular mechanisms of Pristimerin's action in UM.
- To evaluate Pristimerin's potential as a chemotherapeutic agent for UM.
Main Methods:
- Treatment of UM-1 cells with Pristimerin.
- Assessment of cell migration, invasion, reactive oxygen species (ROS) levels, and mitochondrial membrane potential.
- Cell cycle analysis and apoptosis assays.
- Western blot analysis to evaluate protein expression and phosphorylation.
- Pharmacological inhibition and siRNA knockdown of key pathway proteins (PI3K, Akt, FoxO3a).
Main Results:
- Pristimerin significantly inhibited UM-1 cell migration and invasion.
- Pristimerin induced ROS production, decreased mitochondrial membrane potential, and caused G0/G1 cell cycle arrest, leading to apoptosis.
- Pristimerin suppressed Akt and FoxO3a phosphorylation, promoting FoxO3a nuclear accumulation.
- Upregulation of pro-apoptotic proteins (Bim, p27Kip1, cleaved caspase-3, PARP, Bax) and downregulation of anti-apoptotic proteins (Cyclin D1, Bcl-2) were observed.
- Inhibition of the PI3K/Akt/FoxO3a pathway potentiated Pristimerin-induced apoptosis, while FoxO3a knockdown partially abolished its effects.
Conclusions:
- Pristimerin induces apoptotic cell death in UM-1 cells via the PI3K/Akt/FoxO3a signaling pathway.
- Pristimerin demonstrates significant anti-migratory and anti-invasive properties in UM cells.
- These findings support Pristimerin as a promising candidate for the development of novel chemotherapeutic treatments for uveal melanoma.
More Related Videos
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation